| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8402361 | Advanced Drug Delivery Reviews | 2017 | 32 Pages |
Abstract
Companies around the world are exploring the benefits of pharmaceutical nanotechnology (e.g. liposomes and micelles) for delivery of the hydrophobic anti-cancer drug paclitaxel (PTX). These PTX formulations are being evaluated for treatment of pancreatic, small cell lung, breast, ovarian, bladder, gastric, and other types of cancer.127
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Alexandros Marios Sofias, Michael Dunne, Gert Storm, Christine Allen,